Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Alder Biopharmaceuticals revenue
Alder Biopharmaceuticals's revenue is $6.5 million.
What is Alder Biopharmaceuticals's revenue?
- Alder Biopharmaceuticals has 202 employees, and the revenue per employee ratio is $32,178.
- Alder Biopharmaceuticals peak revenue was $6.5M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Alder Biopharmaceuticals financing
Alder Biopharmaceuticals received early financing of $11.0M on 2005-07-01.
| Series | Round size | Date |
|---|---|---|
| Series A | $11M | 07/2005 |
| Series B | $16M | 07/2006 |
| Series C | $40M | 12/2007 |
| Series D | $38M | 04/2012 |
| Post Ipo Equity | $250M | 01/2018 |
| Post Ipo Equity | $170M | 04/2019 |
Alder Biopharmaceuticals investors
| Investors | Security type |
|---|---|
| Sevin Rosen Funds | Series A |
| VENTURES WEST CAPITAL LTD | Series A |
| Washington Research Foundation | Series A |
| H.I.G. Capital Inc. | Series B |
| Sevin Rosen Funds | Series B |
| VENTURES WEST CAPITAL LTD | Series B |
| Washington Research Foundation | Series B |
| WRF Capital | Series B |
| Delphi Ventures | Series C |
| TPG Biotech | Series C |
| Delphi Ventures | Series D |
| Novo Ventures | Series D |
| H.I.G. Capital Inc. | Series D |
| VENTURES WEST CAPITAL LTD | Series D |
| Sevin Rosen Funds | Series D |
| Washington Research Foundation | Series D |
| TPG Biotech | Series D |
| Redmile Group | Post Ipo Equity |
Alder Biopharmaceuticals competitors
Alder Biopharmaceuticals's top competitor, Seagen, earned an annual revenue of $2.0B.
Alder Biopharmaceuticals's smallest competitor is Eureka Therapeutics with revenue of $500.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| AnaptysBio | - | $91.3M | 78 | - |
| Alimera Sciences | - | $80.8M | 154 | - |
| Seagen | - | $2.0B | 900 | - |
| Sorbent Therapeutics | - | - | 31 | - |
| bluebird bio | - | $3.7M | 518 | - |
| Humanigen | - | $2.5M | 10 | - |
| Immunome | - | $9.0M | 29 | - |
| OncoMed Pharmaceuticals | - | $44.4M | 83 | - |
| Xencor | - | $110.5M | 156 | - |
| Pandion Therapeutics | - | $8.8M | 43 | - |
Alder Biopharmaceuticals revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Alder Biopharmaceuticals highest paying jobs
Zippia gives an in-depth look into the details of Alder Biopharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Alder Biopharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Alder Biopharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Alder Biopharmaceuticals. The data presented on this page does not represent the view of Alder Biopharmaceuticals and its employees or that of Zippia.
Alder Biopharmaceuticals may also be known as or be related to ALDER BIOPHARMACEUTICALS INC, Alder BioPharmaceuticals, Alder BioPharmaceuticals Inc, Alder BioPharmaceuticals, Inc., Alder Biopharmaceuticals, Alder Biopharmaceuticals Inc, Alder Biopharmaceuticals Inc. (nasdaq: Aldr) and Alder Biopharmaceuticals, Inc.